JEFFREY SILBERBERG, M.D.
Hematology & Oncology Physician · FREEHOLD, NJ
Individual Active NPI 1922101161
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,254 | 351,007 | $27,160,986 | $7,949,933 | $6,324,491 |
| 2023 | 931 | 206,309 | $14,678,539 | $4,765,146 | $3,789,081 |
| 2022 | 792 | 192,563 | $11,107,825 | $5,285,166 | $4,214,771 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 25,600 | $56 | $45 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 21,000 | $1 | $1 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17,360 | $3 | $2 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 17,200 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 16,740 | $49 | $39 |
| J1756 | Injection, iron sucrose, 1 mg | 12,600 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 12,000 | $0 | $0 |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 5,500 | $6 | $4 |
| J0897 | Injection, denosumab, 1 mg | 5,340 | $26 | $21 |
| J0185 | Injection, aprepitant, 1 mg | 5,330 | $2 | $1 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 4,800 | $20 | $16 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 4,060 | $8 | $6 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | — | NJ |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in New Jersey
- NPI 1134113376
- NPI 1952356198
- NPI 1003181074
- NPI 1255412359
- NPI 1285194969
- NPI 1619059987
- NPI 1518165919
- NPI 1659542702
See all Hematology & Oncology Physician providers in New Jersey →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.